Compendium of Cancer Genome Aberrations

Changes

HAEM5:Volunteer Assignments and Opportunities (view source)

Revision as of 15:13, 20 December 2023

671 bytes added ,  15:13, 20 December 2023
no edit summary
Line 1,432: Line 1,432:  
|
 
|
 
|-
 
|-
−
|Splenic diffuse red pulp small B-cell lymphoma||Disease|| || || || || ||SG|| ||
+
|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| || || || || ||SG|| ||
 
|
 
|
 
|*Snehal Patel, MD, PhD
 
|*Snehal Patel, MD, PhD
Line 1,439: Line 1,439:  
|
 
|
 
|-
 
|-
−
|Splenic B-cell lymphoma/leukaemia with prominent nucleoli
+
|[[HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli|Splenic B-cell lymphoma/leukaemia with prominent nucleoli]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,455: Line 1,455:  
|
 
|
 
|-
 
|-
−
|Lymphoplasmacytic lymphoma
+
|[[HAEM5:Lymphoplasmacytic lymphoma|Lymphoplasmacytic lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,471: Line 1,471:  
|
 
|
 
|-
 
|-
−
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
+
|[[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,487: Line 1,487:  
|
 
|
 
|-
 
|-
−
|Primary cutaneous marginal zone lymphoma
+
|[[HAEM5:Primary cutaneous marginal zone lymphoma|Primary cutaneous marginal zone lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,503: Line 1,503:  
|
 
|
 
|-
 
|-
−
|Nodal marginal zone lymphoma
+
|[[HAEM5:Nodal marginal zone lymphoma|Nodal marginal zone lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,519: Line 1,519:  
|
 
|
 
|-
 
|-
−
|Paediatric nodal marginal zone lymphoma
+
|[[HAEM5:Paediatric nodal marginal zone lymphoma|Paediatric nodal marginal zone lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,535: Line 1,535:  
|
 
|
 
|-
 
|-
−
|In situ follicular B-cell neoplasm
+
|[[HAEM5:In situ follicular B-cell neoplasm|In situ follicular B-cell neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,551: Line 1,551:  
|
 
|
 
|-
 
|-
−
|Follicular lymphoma
+
|[[HAEM5:Follicular lymphoma|Follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,567: Line 1,567:  
|
 
|
 
|-
 
|-
−
|Paediatric-type follicular lymphoma
+
|[[HAEM5:Paediatric-type follicular lymphoma|Paediatric-type follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,583: Line 1,583:  
|
 
|
 
|-
 
|-
−
|Duodenal-type follicular lymphoma
+
|[[HAEM5:Duodenal-type follicular lymphoma|Duodenal-type follicular lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,599: Line 1,599:  
|
 
|
 
|-
 
|-
−
|Primary cutaneous follicle centre lymphoma
+
|[[HAEM5:Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle centre lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,615: Line 1,615:  
|
 
|
 
|-
 
|-
−
|In situ mantle cell neoplasm
+
|[[HAEM5:In situ mantle cell neoplasm|In situ mantle cell neoplasm]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,631: Line 1,631:  
|
 
|
 
|-
 
|-
−
|Mantle cell lymphoma
+
|[[HAEM5:Mantle cell lymphoma|Mantle cell lymphoma]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/13947"